Literature DB >> 3120519

Platelet-activating factor (PAF-acether) formation in rat basophilic leukemia cells stimulated by ionophore A23187.

M Hirafuji1, J F Nave.   

Abstract

In rat basophilic leukemia cells (2 H3-RBL) stimulated with the calcium ionophore A23187, a rapid build-up of PAF-acether was observed within 5 minutes. Thereafter, a slow and complete catabolism was observed within the next 55 minutes. Accumulation of PAF-acether required calcium in the medium and was increased in the presence of acetyl-CoA. Phenyl methyl sulfonyl fluoride, a serine hydrolase inhibitor active on 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine acetyl hydrolase also produced an increased accumulation of PAF-acether in ionophore-stimulated cells. Quinacrine, a non specific inhibitor of phospholipase A2 impaired PAF-acether formation in a dose-dependent manner. The time-course of PAF-acether formation was compared with the ionophore-induced release of arachidonic acid from these cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3120519     DOI: 10.1007/bf01968832

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  26 in total

1.  1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. A common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes.

Authors:  F H Chilton; J M Ellis; S C Olson; R L Wykle
Journal:  J Biol Chem       Date:  1984-10-10       Impact factor: 5.157

2.  Paf-acether formation and arachidonic acid freeing from platelet ether-linked glyceryl-phosphorylcholine.

Authors:  M Chignard; J P Le Couedic; E Coëffier; J Benveniste
Journal:  Biochem Biophys Res Commun       Date:  1984-10-30       Impact factor: 3.575

3.  Release of arachidonic acid from 1-alkyl-2-acyl-sn-glycero-3-phosphocholine, a precursor of platelet-activating factor, in rat alveolar macrophages.

Authors:  D H Albert; F Snyder
Journal:  Biochim Biophys Acta       Date:  1984-10-24

4.  Activation of 1-alkyl-2-lysoglycero-3-phosphocholine. Acetyl-CoA transferase during phagocytosis in human polymorphonuclear leukocytes.

Authors:  F Alonso; M G Gil; M Sánchez-Crespo; J M Mato
Journal:  J Biol Chem       Date:  1982-04-10       Impact factor: 5.157

5.  1-O-alkyl-linked phosphoglycerides of human platelets: distribution of arachidonate and other acyl residues in the ether-linked and diacyl species.

Authors:  H W Mueller; A D Purdon; J B Smith; R L Wykle
Journal:  Lipids       Date:  1983-11       Impact factor: 1.880

6.  Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.

Authors:  J M Mencia-Huerta; R A Lewis; E Razin; K F Austen
Journal:  J Immunol       Date:  1983-12       Impact factor: 5.422

7.  CV-3988 - a specific antagonist of platelet activating factor (PAF).

Authors:  Z Terashita; S Tsushima; Y Yoshioka; H Nomura; Y Inada; K Nishikawa
Journal:  Life Sci       Date:  1983-04-25       Impact factor: 5.037

8.  Biosynthesis of platelet-activating factor (PAF-acether). V. Enhancement of acetyltransferase activity in murine peritoneal cells by calcium ionophore A23187.

Authors:  E Ninio; J M Mencia-Huerta; J Benveniste
Journal:  Biochim Biophys Acta       Date:  1983-05-16

9.  Biosynthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) from 1-alkyl-2-acyl-sn-glycero-3-phosphocholine by rat alveolar macrophages. Phospholipase A2 and acetyltransferase activities during phagocytosis and ionophore stimulation.

Authors:  D H Albert; F Snyder
Journal:  J Biol Chem       Date:  1983-01-10       Impact factor: 5.157

10.  1-O-alkyl-2-acyl-sn-glycero-3-phosphorylcholine is the precursor of platelet-activating factor in stimulated rabbit platelets. Evidence for an alkylacetyl-glycerophosphorylcholine cycle.

Authors:  L Touqui; C Jacquemin; C Dumarey; B B Vargaftig
Journal:  Biochim Biophys Acta       Date:  1985-01-09
View more
  1 in total

1.  Inhibition of lysoPAF acetyltransferase activity by flavonoids.

Authors:  R Yanoshita; H W Chang; K H Son; I Kudo; Y Samejima
Journal:  Inflamm Res       Date:  1996-11       Impact factor: 4.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.